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Abstract: 
Objectives: They studied the associations of genetic polymorphisms with clinico-laboratory indicators among 
pregnant women with preeclampsia depending on hereditary complication. 
Materials and Methods: The study was conducted among 274 pregnant women with preeclampsia. They studied the 
polymorphisms of five folate cycle genes (+677ɋ>Ɍ MɌHFR (rs1801133), +1298А>ɋ MɌHFR (rs1801131), -
1053ɋ>Ɍ ɌYMS (rs699517), IVS6-68ɋ>Ɍ ɌYМS (rs1059394), -1122А>G ɌYMS rs2790). 
Results: The genotypes -1053CT TYMS and -1053TT TYMS are associated with an increased level of proteinuria 
among the pregnant women without a complicated family history. The polymorphisms -1053CT TYMS and -1053TT 
TYMS, IVS6-68CT TYMS and IVS6-68TT TYMS are associated with a higher level of glucose in blood, and the 
genotypes +1298S MTHFR and + 1298AC MTHFR are interrelated with an increased activated partial 
thromboplastin time in the group of pregnant women with a family history. 
Conclusions: the performed study determined significant associations of folate metabolism genes with an increased 
level of proteinuria, glucose, and APTT among pregnant women with preeclampsia, depending on the presence of a 
complicated family history. 
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INTRODUCTION: 
Preeclampsia (PE) - is a complication of pregnancy, 
arisingin the period of late pregnancy and 
characterizing by the appearance of oedemata, 
proteinuria, arterial hypertension, as well as by deep 
disorders of the vascular system, hemostasis, 
immunity, hemodynamics and microcirculation, 
fetoplacental insufficiency, decreased kidney 
function, liver and lungs functions (Williams et al, 
2011; Sidorova, 2016). The frequency of PE is 8-20% 
among all pregnant Suhih, Murashko, 2010). During 
the last decade, preeclampsia is one of the main 
factors of perinatal morbidity in the world, and stably 
ranks № 3-4 in the structure of the causes of maternal 
morbidity and mortality (Ajlamazyan, Mozgovaya, 
2010, Sidorova, 2016). 
 
Genetic component of PE development can account 
for up to 50% of all risk factors (Baranov, 2009). 
 
An important role in the etiology and pathogenesis of 
preeclampsia belongs to the candidategenes of folate 
metabolism (Vorozhinceva, 2014, Zhou et al., 2016). 
Mutations in the genes of folate metabolism, causing 
a decrease in the enzymes activity of 
methyltetrahydrofolatereductase and methionine 
synthase reductase, lead to excessive accumulation of 
homocysteinein the blood and, as a consequence, 
disruption of methylation processes in cells 
(Vorozhinceva, 2014). Deficiency of folic acid causes 
the formation of hypertension in pregnant women, the 
development of total angiopathy, microthrombosis, 
the increase of insulin resistance. It should be noted, 
that the role of candidate gens of folate metabolism in 
the formation of PE is actively investigated, but these 
studies often give conflicting results in different 
populations of the world (Obolenska et al., 2011; 
Pavlova et al, 2011; Williams et al, 2011; Valenzuela 
et al. al, 2012; Vorozhinceva, 2014; Reilly et al, 
2014). 
 
MATERIALS AND METHODS: 
Object of study 
The study group included 274 pregnant women, 
diagnosed with preeclampsia. 105 of them had 
hereditary burden for preeclampsia and 169 pregnant 
women hadn’t genetic disposition to preeclampsia. 
The average age of women with PE was 27.19± 6.4. 
All clinical studies were carried out according to the 
protocols of ethical committee of the Russian 
Federation, with the informed consent of the patients. 
The present study includes persons of Russian 
nationality, born in the Central Black Earth region of 
Russia, who do not have genetic relationships. 
Clinical and laboratory examination of women from 
the main and control groups was performed at the  
 
delivery time, in the Perinatal Center of the Belgorod 
Regional Clinical Hospital of St. Joasaph. 
 
Oedemata, arterial hypertension and proteinuria were 
the base for the diagnosis of preeclampsia (Turner, 
2010). Exclusion criteria for the formation of the 
sample were the following: the presence of uterine 
pathology (uterine fibroids, internal genital 
abnormalities), pathology of pregnancy (anomalies of 
placentation and location of placenta, rhesus-
conflict), fetal pathology (congenital malformations), 
multifetal pregnancy. 
 
All pregnant women were examined in laboratory 
conditions, including: general blood test, 
coagulogram, biochemical blood test, general urine 
test (protein, specific gravity, epithelium, leukocytes, 
cylinders), Nechiporenko test, Zimnitskiy test 
(leukocytes, erythrocytes). 
 
Molecular and genetic methods 
Typing of polymorphic variants of folate cycle genes 
of methylenetetrahydrofolatereductase (+677ɋ>Ɍ 
MɌHFR (rs1801133), +1298А>ɋMɌHFR 
(rs1801131)), thymidylatesynthetase (-1053ɋ>Ɍ 
ɌYMS (rs699517), IVS 6-68 ɋ>ɌɌYМS (rs1059394), 
-1122А>G ɌYMS (rs2790)) was carried out for all 
pregnant women with preeclampsia, and pregnant 
control group, on the basis of the research laboratory 
"Human molecular genetics" of Belgorod State 
National Research University. The material for the 
study was venous blood, obtained in a volume of 8-9 
ml from the ulnar vein of pregnant women. All 
polymorphic variants of folate cycle enzymes were 
analyzed using the method of polymerase chain 
reaction (PCR) of DNA synthesis in real-time (Real-
time-PCR). 
 
Statistical methods 
Formation of the database and statistical calculations 
were carried out using the program "STATISTICA 
6.0". Gene and phenotypic frequencies were 
calculated using the standard methods. The 
conformity of the observed distribution of genotypes 
to the expected one, according to the Hardy-
Weinberg equilibrium, was performed using the χ2 
criterion. In order to minimize the errors of the first 
kind (false positive results), the Bonferronicorrection 
was used when carrying out multiple comparisons. 
The study of the connections of polymorphic variants 
with pathogenetically significant continuous 
characters of PE (blood pressure level, fibrinogen 
level, prothrombin index, etc.) was carried out using 
nonparametric statistics (Rebrova, 2006). 
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RESULTS: 
The studied clinical and laboratory parameters 
(proteinuria, the content of fibrinogen, total protein, 
urea and creatinine in blood, activated partial 
thromboplastin time, thrombin time) in pregnant 
women with preeclampsia are presented in Table 1. 
 
 
Table 1: The distribution of clinical and laboratory parameters in the study group of women with preeclampsia 
 
 
Note: APTT - activated partial thromboplastin time, TT - thrombin time. 
 
As a result of the study, it was found, that women 
with PE, without hereditary burden, with genotypes -
1053ɋɌ ɌYMS and -1053ɌɌ ɌYMS, have higher level 
of proteinuria (Ме= 0.066 g/l, Q10-Q90 = 0.33-0.163 
g/l), than women with the genotype -1053ɋɋ ɌYMS 
for the given locus (Me= 0.085 g/l, Q10-Q90 = 0.033-
0.124 g/l, p = 0.04, respectively). 
 
In pregnant women with PE, having burdened 
familial history, with genotypes -1053ɌɌ ɌYMS and -
1053ɋɌ ɌYMS, the glucose level in blood (Me= 4.30 
mmol/l, Q10-Q90 = 3.86-4.90 mmol/l) is statistically 
significantly higher, than that of women with the 
genotype-1053ɋɋ ɌYMS (Me= 3.8 mmol/l, Q10-Q90 
= 3.55-4.25 mmol/l, p = 0.004). In women with PE, 
with hereditary burden, having the genotypes 
+1298Аɋ MɌHFR и +1298ɋɋMɌHFR, the level of 
APTT (Me= 35.0 s, Q25-Q75 = 30.0-36.0 s) is higher, than that of individuals with genotype + 1298АА 
MɌHFR (Me= 30.0 s, Q25-Q75 = 27.50-35.0 s, p = 
0.03). 
 
In pregnant women with genotypes IVS6-68ɋɌ 
ɌYMS and IVS6-68ɌɌ ɌYMS, the glucose level in 
blood (Me= 4.40 g/l, Q25-Q75 = 3.88-4.90 g/l) is 
higher than in women with genotype IVS6-68ɋɋ 
ɌYMS (Me= 3.80 g/l, Q25-Q75 = 3.50-4.30 g/l, p = 
0.006). 
 
DISCUSSION: 
As the results of this study indicate, polymorphisms 
of folate metabolism genes (+1298А>ɋMɌHFR, -
1053ɋ>Ɍ ɌYMS, IVS 6-68 ɋ>ɌɌYМS) have an 
important pathogenetic significance in the formation 
of clinical and laboratory parameters in pregnant 
women with PE. Genetic variants -1053ɋɌ ɌYMS 
and -1053ɌɌ ɌYMS are associated with the increased 
level of proteinuria in the group of pregnant women 
with PE, without a burdened familial history. 
Polymorphic variants -1053ɋɌ ɌYMS and -1053ɌɌ 
ɌYMS, IVS6-68ɋɌ ɌYMS and IVS6-68ɌɌ ɌYMS are 
connected with higher level of glucose in blood, and 
the genotypes +1298ɋɋ MɌHFR and +1298Аɋ 
MɌHFR are associated with an increased APTT, in 
the group of pregnant women with PE, having a 
burdened familial history.  
Parameters 
Lower 
quartile, 
(Q25) 
Median, (Me) 
Upper 
quartile, 
(Q75) 
Shapiro-
Wilk 
statistics 
Level of 
significance (p) 
Proteinuria, g/l 0.03 0.06 0.12 0.48 0.000000 
The content of fibrinogen in 
blood, g/l 3.70 4.20 5.00 0.98 0.00004 
APTT, s 29.00 35.00 37.00 0.97 0.000001 
TT, s 14.00 15.00 15.00 0.88 0.000000 
The total protein content in 
blood, g/l 61.00 65.15 69.00 0.99 0.01 
Urea content in blood, mmol/l 3.57 4.40 7.10 0.89 0.000000 
Creatinine level in blood, 
μmol/l 64.00 72.00 84.00 0.98 0.0001 
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The following medical and biological mechanisms 
can be the base of revealed by us associations of 
genetic polymorphisms of folate cycle genes with 
clinical-laboratory parameters of women with PE. 
The decrease in the activity of folate cycle enzymes 
(in individuals with genetic variants +1298ɋɋ 
MɌHFR, +1298Аɋ MɌHFR) leads to the disruption 
in the delivery and metabolism of folic acid, the 
accumulation of homocysteinein the blood plasma 
and the development of hyperhomocysteinemia 
(Suhovolskaya et al, 2012). Herewith, homocysteine
begins to show its toxic properties, which primarily 
concern the vessel wall. According to the literature, a 
high level of homocysteinemia (HC) is a risk factor 
for the development of both atherosclerotic and 
thrombogenicvascular diseases. An increase in the 
concentration of homocysteineincreases oxidative 
stress, stimulates the production of smooth muscle 
cells, and alters the elastic properties of the vessel 
wall (Makacariya, 2004; Zajnulina et al, 2005). The 
malfunction of microcirculation increases 
permeability of blood vessels, that leads to 
deterioration of rheological properties of blood, 
slowing of blood flow in the microvasculature, 
increasing of peripheral resistance and, consequently, 
to hypertension; that, in turn, increases the risk of 
preeclampsia and the severity of its manifestations 
(proteinuria, hypoproteinemia) (Bolshakova, 2004; 
Baranova, 2006). 
 
In various studies on the search for associations of 
folate cycle genes with clinical-laboratory parameters 
in pregnant women, conflicting results were obtained. 
Thus, in the Portuguese population, the genotype 
+677TT MTHFR was associated with a decrease in 
SBP and DBP, in women with gestational 
hypertension (Matos et al, 2013). And in the study of 
Yakut, Buryat and Russian populations, the 
associations of polymorphism +677C>T MTHFRwith 
blood pressure, proteinuria and hypoproteinemiawere 
not revealed in pregnant women with preeclampsia 
(Vorozhishcheva, 2014). In a similar study, 
conducted on the Russian population of Central 
Russia, there were also no associations of 
polymorphic marker of gene MTHFR with 
proteinuria and arterial hypertension, in case of 
preeclampsia (Halford-Knyazeva, 2013). 
 
The  inconsistency of the results, obtained in 
various studies, may be related to the differences in 
the ethnic and, respectively, genetic background of 
the studied populations (Churnosov et al, 2005, 
Sorokina et al, 2007). This feature of the Russian 
gene pool determines the need to take into account 
the population sample, for which the results are 
obtained. 
 
SUMMARY: 
Thus, as a result of this study, significant associations 
of folate metabolism genes with increased levels of 
proteinuria, glucose, and APTT in pregnant women 
with preeclampsia were established, depending on the 
burdened familial history. 
 
CONCLUSION: 
The results of this study broaden the concept of 
molecular and genetic determinants of preeclampsia 
development. The obtained data can be used in the 
work of  women’s consultation clinics and obstetric-
gynecologic hospitals, with the purpose to identify 
the groups with an increased risk of preeclampsia 
development, among women in preconception period 
andat the early stages of pregnancy. 
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